These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 33736701)

  • 41. Cerebrospinal Fluid (CSF) Exchange with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Experimental Autoimmune Encephalomyelitis.
    Valitsky M; Benhamron S; Nitzan K; Karussis D; Ella E; Abramsky O; Kassis I; Rosenmann H
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30978957
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Efficacy and Safety of Intrathecal Autologous Bone Marrow-Derived Mesenchymal Stromal Cells in Amyotrophic Lateral Sclerosis: A Pilot Study.
    Shamsaei G; Houshmand F; Ahmadzadeh Deylami A; Valizadeh A; Rafie S; Moradi M
    Adv Pharm Bull; 2023 Mar; 13(2):361-367. PubMed ID: 37342380
    [No Abstract]   [Full Text] [Related]  

  • 43. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial.
    Mazzini L; Ferrero I; Luparello V; Rustichelli D; Gunetti M; Mareschi K; Testa L; Stecco A; Tarletti R; Miglioretti M; Fava E; Nasuelli N; Cisari C; Massara M; Vercelli R; Oggioni GD; Carriero A; Cantello R; Monaco F; Fagioli F
    Exp Neurol; 2010 May; 223(1):229-37. PubMed ID: 19682989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NurOwn, phase 2, randomized, clinical trial in patients with ALS: Safety, clinical, and biomarker results.
    Berry JD; Cudkowicz ME; Windebank AJ; Staff NP; Owegi M; Nicholson K; McKenna-Yasek D; Levy YS; Abramov N; Kaspi H; Mehra M; Aricha R; Gothelf Y; Brown RH
    Neurology; 2019 Dec; 93(24):e2294-e2305. PubMed ID: 31740545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Autologous mesenchymal stromal cells as a therapeutic in ALS and epilepsy patients: Treatment modalities and ex vivo neural differentiation.
    Shakhbazau A; Potapnev M
    Cytotherapy; 2016 Oct; 18(10):1245-55. PubMed ID: 27426933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification and validation of multiple cell surface markers of clinical-grade adipose-derived mesenchymal stromal cells as novel release criteria for good manufacturing practice-compliant production.
    Camilleri ET; Gustafson MP; Dudakovic A; Riester SM; Garces CG; Paradise CR; Takai H; Karperien M; Cool S; Sampen HJ; Larson AN; Qu W; Smith J; Dietz AB; van Wijnen AJ
    Stem Cell Res Ther; 2016 Aug; 7(1):107. PubMed ID: 27515308
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.
    Tanna T; Sachan V
    Curr Stem Cell Res Ther; 2014; 9(6):513-21. PubMed ID: 25248677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal Fluid (CSF) Exchange Therapy with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Cognitive Deficits and Brain Pathology in Alzheimer's Disease Mice.
    Benhamron S; Nitzan K; Valitsky M; Lax N; Karussis D; Kassis I; Rosenmann H
    J Alzheimers Dis; 2020; 76(1):369-385. PubMed ID: 32474465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses.
    Barberini DJ; Aleman M; Aristizabal F; Spriet M; Clark KC; Walker NJ; Galuppo LD; Amorim RM; Woolard KD; Borjesson DL
    Stem Cell Res Ther; 2018 Apr; 9(1):96. PubMed ID: 29631634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress.
    Wu X; Jiang J; Gu Z; Zhang J; Chen Y; Liu X
    Stem Cell Res Ther; 2020 Aug; 11(1):345. PubMed ID: 32771052
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MIS416 Enhances Therapeutic Functions of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Against Experimental Colitis by Modulating Systemic Immune Milieu.
    Lee BC; Shin N; Lee JY; Kang I; Kim JJ; Lee SE; Choi SW; Webster GA; Kang KS
    Front Immunol; 2018; 9():1078. PubMed ID: 29892282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
    De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
    Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling.
    Roson-Burgo B; Sanchez-Guijo F; Del Cañizo C; De Las Rivas J
    BMC Genomics; 2016 Nov; 17(1):944. PubMed ID: 27871224
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis.
    Boucherie C; Schäfer S; Lavand'homme P; Maloteaux JM; Hermans E
    J Neurosci Res; 2009 Jul; 87(9):2034-46. PubMed ID: 19267424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect and mechanism of marrow stromal cells within cerebrospinal fluid on SOD1 transgenic mice].
    Zhou C; Zhang C; Yao QQ; Zhao CP; Zhang C
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(29):2324-8. PubMed ID: 24300157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?
    Allers C; Jones JA; Lasala GP; Minguell JJ
    Regen Med; 2014; 9(5):637-47. PubMed ID: 25372079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis.
    Kassis I; Grigoriadis N; Gowda-Kurkalli B; Mizrachi-Kol R; Ben-Hur T; Slavin S; Abramsky O; Karussis D
    Arch Neurol; 2008 Jun; 65(6):753-61. PubMed ID: 18541795
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inflammatory licensed equine MSCs are chondroprotective and exhibit enhanced immunomodulation in an inflammatory environment.
    Cassano JM; Schnabel LV; Goodale MB; Fortier LA
    Stem Cell Res Ther; 2018 Apr; 9(1):82. PubMed ID: 29615127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced sirtuin 1/adenosine monophosphate-activated protein kinase in amyotrophic lateral sclerosis patient-derived mesenchymal stem cells can be restored by resveratrol.
    Yun YC; Jeong SG; Kim SH; Cho GW
    J Tissue Eng Regen Med; 2019 Jan; 13(1):110-115. PubMed ID: 30479062
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
    Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
    Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.